. Anon, Estimated cancer incidence, mortality and prevalence worlwide in 2012, 2017.

. Anon, Rapport InVS, 2013.

, European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma, J. Hepatol, vol.56, issue.4, pp.908-943, 2012.

. Anon, Carcinome hépatocellulaire | SNFGE.org-Société savante médicale française d"hépato-gastroentérologie et d"oncologie digestive

. Accessed, , 2017.

J. Bruix, M. Sherman, and J. M. Llovet, Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver, J. Hepatol, vol.35, issue.3, pp.421-430, 2001.

J. Bruix and M. Sherman, Practice Guidelines Committee, Management of hepatocellular carcinoma. Hepatol. Baltim. Md, vol.42, issue.5, pp.1208-1236, 2005.

J. Bruix and M. Sherman, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update, Hepatol. Baltim. Md, vol.53, issue.3, pp.1020-1022, 2011.

, Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia, Hepatol. Baltim. Md, vol.49, issue.2, pp.658-664, 2009.

A. Forner, M. E. Reig, and C. R. De-lope, Current strategy for staging and treatment: the BCLC update and future prospects, Semin. Liver Dis, vol.30, issue.1, pp.61-74, 2010.

S. Collette, F. Bonnetain, and X. Paoletti, Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.19, issue.6, pp.1117-1126, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00363734

R. Lencioni and J. M. Llovet, Modified RECIST (mRECIST) assessment for hepatocellular carcinoma, Semin. Liver Dis, vol.30, issue.1, pp.52-60, 2010.
DOI : 10.1055/s-0030-1247132

URL : http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0030-1247132.pdf

V. Yaghmai, C. Besa, and E. Kim, Imaging assessment of hepatocellular carcinoma response to locoregional and systemic therapy, AJR Am. J. Roentgenol, vol.201, issue.1, pp.80-96, 2013.
DOI : 10.2214/ajr.13.10706

P. V. Pandharipande, G. A. Krinsky, and H. Rusinek, Perfusion imaging of the liver: current challenges and future goals, Radiology, vol.234, issue.3, pp.661-673, 2005.
DOI : 10.1148/radiol.2343031362

S. H. Kim, A. Kamaya, and J. K. Willmann, CT perfusion of the liver: principles and applications in oncology, Radiology, vol.272, issue.2, pp.322-344, 2014.

M. Ronot, S. Lambert, and J. Daire, Can we justify not doing liver perfusion imaging in 2013?, Diagn. Interv. Imaging, vol.94, issue.12, pp.1323-1336, 2013.
DOI : 10.1016/j.diii.2013.06.005

URL : https://doi.org/10.1016/j.diii.2013.06.005

C. S. Ng, A. G. Chandler, and W. Wei, Effect of dual vascular input functions on CT perfusion parameter values and reproducibility in liver tumors and normal liver, J. Comput. Assist. Tomogr, vol.36, issue.4, pp.388-393, 2012.

T. Lee, Functional CT: physiological models, Trends Biotechnol, vol.20, issue.8, pp.3-10, 2002.
DOI : 10.1016/s0167-7799(02)02035-8

K. A. Miles, T. Lee, and V. Goh, Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography, Eur. Radiol, vol.22, issue.7, pp.1430-1441, 2012.

A. Chandler, W. Wei, and E. F. Anderson, Validation of motion correction techniques for liver CT perfusion studies, Br. J. Radiol, vol.85, pp.514-522, 1016.
DOI : 10.1259/bjr/31999821

URL : http://europepmc.org/articles/pmc3587085?pdf=render

C. S. Ng, A. G. Chandler, and W. Wei, Reproducibility of CT perfusion parameters in liver tumors and normal liver, Radiology, vol.260, issue.3, pp.762-770, 2011.
DOI : 10.1148/radiol.11110331

URL : http://europepmc.org/articles/pmc3156998?pdf=render

V. Delmon, Recalage déformable de projections de scanner X à faisceau conique. Th. Imagerie médicale, INSA de Lyon, 2013.

B. Monmege, Validation d'algorithmes de recalage non rigide appliqués aux images médicales, 2007.

S. Sourbron, Technical aspects of MR perfusion, Eur. J. Radiol, vol.76, issue.3, pp.304-313, 2010.
DOI : 10.1016/j.ejrad.2010.02.017

E. Y. Tsui, J. H. Chan, and Y. K. Cheung, Evaluation of therapeutic effectiveness of transarterial chemoembolization for hepatocellular carcinoma: correlation of dynamic susceptibility contrast-enhanced echoplanar imaging and hepatic angiography, Clin. Imaging, vol.24, issue.4, pp.210-216, 2000.

G. Jahng, K. Li, and L. Ostergaard, Perfusion magnetic resonance imaging: a comprehensive update on principles and techniques, Korean J. Radiol, vol.15, issue.5, pp.554-577, 2014.
DOI : 10.3348/kjr.2014.15.5.554

URL : http://synapse.koreamed.org/Synapse/Data/PDFData/0068KJR/kjr-15-554.pdf

A. Parkin, P. Robinson, and P. Baxter, Liver perfusion scintigraphy : method, normal range and laparotomy correlation in 100 patients, Nucl Med Commun, vol.4, issue.6, pp.395-402, 1983.
DOI : 10.1097/00006231-198304060-00003

N. Kudomi, L. Slimani, and M. J. Järvisalo, Non-invasive estimation of hepatic blood perfusion from H2 15O PET images using tissue-derived arterial and portal input functions, Eur. J. Nucl. Med. Mol. Imaging, vol.35, issue.10, pp.1899-1911, 2008.
DOI : 10.1007/s00259-008-0796-z

URL : https://hal.archives-ouvertes.fr/inserm-00402763

M. Winterdahl, O. L. Munk, and M. Sørensen, Hepatic blood perfusion measured by 3-minute dynamic 18F-FDG PET in pigs, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.52, issue.7, pp.1119-1124, 2011.
DOI : 10.2967/jnumed.111.088278

URL : http://jnm.snmjournals.org/content/52/7/1119.full.pdf

D. V. Sahani, N. Holalkere, and P. R. Mueller, Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue-initial experience, Radiology, vol.243, issue.3, pp.736-743, 2007.
DOI : 10.1148/radiol.2433052020

D. Ippolito, C. Capraro, and A. Casiraghi, Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging, Eur. Radiol, vol.22, issue.4, pp.803-811, 2012.

D. Ippolito, S. Sironi, and M. Pozzi, Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization, Acad. Radiol, vol.15, issue.7, pp.919-927, 2008.

F. Du, R. Jiang, and M. Gu, The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma, Radiol. Med. (Torino), vol.120, issue.8, pp.690-694, 2015.

M. A. Fischer, N. Kartalis, and A. Grigoriadis, Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis, Eur. Radiol, vol.25, issue.11, pp.3123-3132, 2015.

H. F. Yang, Y. Du, and J. X. Ni, Perfusion computed tomography evaluation of angiogenesis in liver cancer, Eur. Radiol, vol.20, issue.6, pp.1424-1430, 2010.

R. Bai, J. Li, and S. Ren, A correlation of computed tomography perfusion and histopathology in tumor edges of hepatocellular carcinoma, Hepatobiliary Pancreat. Dis. Int. HBPD INT, vol.13, issue.6, pp.612-617, 2014.

G. Grözinger, M. Bitzer, and R. Syha, Correlation of magnetic resonance signal characteristics and perfusion parameters assessed by volume perfusion computed tomography in hepatocellular carcinoma: Impact on lesion characterization, World J. Radiol, vol.8, issue.7, pp.683-692, 2016.

S. Kaufmann, T. Horger, and A. Oelker, Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique, Eur. J. Radiol, vol.84, issue.6, pp.1029-1035, 2015.

D. Ippolito, D. Fior, and P. A. Bonaffini, Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients, Eur. J. Radiol, vol.83, issue.9, pp.1665-1671, 2014.

D. Ippolito, P. Bonaffini, and L. Ratti, Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor, World J. Gastroenterol, vol.16, issue.47, pp.5993-6000, 2010.

D. Ippolito, D. Fior, and C. T. Franzesi, Tumour-related neoangiogenesis: functional dynamic perfusion computed tomography for diagnosis and treatment efficacy assessment in hepatocellular carcinoma, Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver, vol.46, issue.10, pp.916-922, 2014.

S. Kaufmann, T. Horger, and A. Oelker, Volume perfusion computed tomography (VPCT)-based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: Impact on tumor and liver parenchymal vascularisation, Eur. J. Radiol, 2015.

L. Yang, X. Zhang, and B. Tan, Computed tomographic perfusion imaging for the therapeutic response of chemoembolization for hepatocellular carcinoma, J. Comput. Assist. Tomogr, vol.36, issue.2, pp.226-230, 2012.

R. De-robertis, T. Martini, P. Demozzi, and E. , Prognostication and response assessment in liver and pancreatic tumors: The new imaging, World J. Gastroenterol, vol.21, issue.22, pp.6794-6808, 2015.

M. R. Meijerink, J. Waesberghe, . Van, L. Weide, and . Van-der, Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases, Eur. Radiol, vol.18, issue.10, p.2345, 2008.

C. Hatwell, M. Zappa, and M. Wagner, Detection of liver micrometastases from colorectal origin by perfusion CT in a rat model, Hepatobiliary Pancreat. Dis. Int. HBPD INT, vol.13, issue.3, pp.301-308, 2014.

B. E. Van-beers, I. Leconte, and R. Materne, Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity, AJR Am. J. Roentgenol, vol.176, issue.3, pp.667-673, 2001.

M. Ronot, T. Asselah, and V. Paradis, Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT, Radiology, vol.256, issue.1, pp.135-142, 2010.

H. O?ul, M. Kantarc?, and B. Genç, Perfusion CT imaging of the liver: review of clinical applications, Diagn. Interv. Radiol. Ank. Turk, vol.20, issue.5, pp.379-389, 2014.

. Anon and . Globocan, , 2012.

G. Chen, D. Ma, and W. He, Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma, World J. Gastroenterol, vol.14, issue.37, pp.5738-5743, 2008.

V. Vilgrain, Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: hepatocellular carcinoma: imaging in assessing treatment efficacy, J. Hepato-Biliary-Pancreat. Sci, vol.17, issue.4, pp.374-379, 2010.
DOI : 10.1007/s00534-009-0230-3

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1007/s00534-009-0230-3

W. Schima, A. Ba-ssalamah, and A. Kurtaran, Post-treatment imaging of liver tumours, Cancer Imaging Off. Publ. Int. Cancer Imaging Soc, vol.7, pp.28-36, 2007.
DOI : 10.1102/1470-7330.2007.9047

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727978/pdf/ci079047.pdf

J. Blanc, J. Barbare, and V. Boige, Thésaurus National de Cancérologie Digestive

S. Delumeau, J. Lebigot, and C. Ridereau-zins, Imaging features and evaluation of liver lesions after non-surgical therapy

, J. Radiol, vol.92, issue.7-8, pp.632-658, 2011.

N. Negi, T. Yoshikawa, and Y. Ohno, Hepatic CT perfusion measurements: a feasibility study for radiation dose reduction using new image reconstruction method, Eur. J. Radiol, vol.81, issue.11, pp.3048-3054, 2012.

L. Yang, X. M. Zhang, and X. P. Zhou, Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization

, J. Vasc. Interv. Radiol. JVIR, vol.21, issue.12, pp.1841-1846, 2010.